Forward Citations = 27

Loading Chart...

4 inventors (with patents filed for the assignee):

Scott Lyman (14 out of 14 patents)

Barry Bleske (11 out of 11 patents)

Ted William Lanpher (9 out of 10 patents)

4. Brian Taubenheim (5 out of 5 patents)

16 patents: Sort by Forward Citations

1. 12728092 - Dry powder formulations of epinephrine and associated methods (2026-09-08),

2. 12678574 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2026-07-14),

3. 12678404 - Dry powder formulations of epinephrine and associated methods (2026-07-14),

4. 12661315 - Dry powder formulations of epinephrine and associated methods (2026-06-23),

5. 12653972 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2026-06-16),

6. 12653778 - Dry powder formulations of epinephrine and associated methods (2026-06-16),

7. 12616807 - Medical counter measures including dry powder formulations and associated methods (2026-05-05),

8. 12605517 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2026-04-21),

9. 12502498 - Compositions, devices, and methods for intranasal delivery of dry powder epinephrine (2025-12-23),

10. 12414916 - Dry powder formulations of epinephrine and associated methods (2025-09-16),

11. 12102629 - Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides (2024-10-01),

12. 12097287 - Dry powder formulations of epinephrine and associated methods (2024-09-24),

13. 12005185 - Medical counter measures including dry powder formulations and associated methods (2024-06-11),

14. 11872308 - Dry powder formulations of epinephrine and associated methods (2024-01-16),

15. 11617716 - Dry powder formulations of epinephrine and associated methods (2023-04-04),

Company Overview

Belhaven Biopharma, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative therapies for unmet medical needs. The organization specializes in advancing drug candidates through various stages of research and development, particularly in the fields of oncology and neurology. With a commitment to scientific excellence, Belhaven Biopharma aims to leverage cutting-edge technologies to create effective treatments that improve patient outcomes and enhance quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#51 in Durham, NC

#443 in North Carolina

#19,922 in US

#37,831 in the World

Durham, NC, United States of America

Belhaven Biopharma, Inc.

Forward Citations = 27

4 inventors:

Scott Lyman (14 out of 14 patents)

Barry Bleske (11 out of 11 patents)

Ted William Lanpher (9 out of 10 patents)

4. Brian Taubenheim (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Belhaven Biopharma, Inc.. Retrieved from https://idiyas.com/company/belhaven-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]